中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

19 records (took 0.013 seconds)

    AUTOMATED SUPER BOLUS GENERATION
    1.
    发明申请
    AUTOMATED SUPER BOLUS GENERATION 有权

    公开(公告)号：US20220257858A1

    公开(公告)日：2022-08-18

    申请号：US17179070

    申请日：2021-02-18

    Applicant: Medtronic MiniMed, Inc.

    Inventor： Benyamin Grosman ,  Louis J. Lintereur ,  Anirban Roy ,  Neha J. Parikh ,  Di Wu ,  Patrick E. Weydt ,  David Dunleavy ,  Ali Dianaty

    IPC: A61M5/172

    Abstract: Techniques related to automatically generating a super bolus may include determining an amount of an augmented meal bolus to be delivered to a patient for regulating the patient's glycemic response to a meal. The amount of the augmented meal bolus may exceed a sufficient amount for counteracting a glucose level increase caused by the meal. In some embodiments, the techniques may further include determining a duration of a postprandial reduction period during which basal dosage deliveries to the patient are to be reduced. In some other embodiments, the techniques may further include delivering the augmented meal bolus to the patient prior to determining whether or not to cause reduction of basal dosage deliveries. More specifically, a glucose level of the patient may be obtained after delivery of the augmented meal bolus, and the obtained glucose level may be used to determine whether to reduce basal dosage deliveries.

    Insulin infusion device with efficient confirmation routine for blood glucose measurements
    2.
    发明授权
    Insulin infusion device with efficient confirmation routine for blood glucose measurements 有权

    公开(公告)号：US11071821B2

    公开(公告)日：2021-07-27

    申请号：US16419411

    申请日：2019-05-22

    Applicant: MEDTRONIC MINIMED, INC.

    Inventor： Louis J. Lintereur ,  Alexander S. Campbell ,  Taly G. Engel ,  David Dunleavy ,  Benyamin Grosman ,  Anirban Roy

    IPC: A61M5/172 ,  G16H20/17

    Abstract: An insulin infusion device and a related operating method are disclosed. The method obtains a blood glucose (BG) measurement of a blood sample from a user, displays the BG measurement on a display element of the infusion device, and receives a confirmation input that indicates user acceptance of the displayed BG measurement. In response to the confirmation input, a glucose sensor calibration routine is automatically initiated, and an insulin bolus calculation is automatically initiated. The calibration routine and the bolus calculation use the confirmed BG measurement. The method continues by controlling delivery of insulin, in accordance with the calculated insulin bolus, from a fluid reservoir of the insulin infusion device. The sensor calibration routine and the insulin bolus calculation are both performed without any additional user involvement or interaction with the user interface other than the user acceptance of the displayed BG measurement.

    GESTURE-BASED CONTROL OF DIABETES THERAPY
    5.
    发明申请
    GESTURE-BASED CONTROL OF DIABETES THERAPY 有权

    公开(公告)号：US20210060247A1

    公开(公告)日：2021-03-04

    申请号：US17004969

    申请日：2020-08-27

    Applicant: Medtronic MiniMed, Inc.

    Inventor： Patrick E. Weydt ,  Pratik J. Agrawal ,  Louis J. Lintereur ,  Lavie Golenberg ,  David Dunleavy

    IPC: A61M5/172 ,  A61M5/142 ,  A61K38/28 ,  G16H40/67 ,  G16H20/17 ,  G16H70/40 ,  G16H40/20

    Abstract: Devices, systems, and techniques for controlling delivery of therapy for diabetes are described. In one example, a system includes a wearable device configured to generate user activity data associated with an arm of a user; and one or more processors configured to: identify at least one gesture indicative of utilization of an injection device for preparation of an insulin injection based on the user activity data; based on the at least one identified gesture, generate information indicative of at least one of an amount or type of insulin dosage in the insulin injection by the injection device; compare the generated information to a criteria of a proper insulin injection; and output information indicative of whether the criteria is satisfied based on the comparison.

    PREDICTION BASED DELIVERING OR GUIDING OF THERAPY FOR DIABETES
    8.
    发明申请
    PREDICTION BASED DELIVERING OR GUIDING OF THERAPY FOR DIABETES 有权

    公开(公告)号：US20210060246A1

    公开(公告)日：2021-03-04

    申请号：US17004951

    申请日：2020-08-27

    Applicant: Medtronic MiniMed, Inc.

    Inventor： Patrick E. Weydt ,  Pratik J. Agrawal ,  Louis J. Lintereur ,  Lavie Golenberg ,  David Dunleavy

    IPC: A61M5/172 ,  A61M5/142 ,  A61K38/28 ,  G16H20/17 ,  G16H20/60 ,  G16H40/67 ,  G06N3/08

    Abstract: An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.

Patent Agency Ranking